Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
In an oncofertility consultation, you are an urgent case and providers have to think about different ways to help you navigate care.
The survival improvement did not come at the cost of safety; the investigators saw no increase in serious side effects.
When you ask patients what’s most important to them, they want to know what’s going to help them live longer overall.
Including patients and patient advocates in the research enterprise is not only valuable but also expected.
With modern chemotherapy regimens, “no child with ALL really should get prophylactic radiation,” said Ching-Hon Pui, MD.
For decades, researchers have sought to better understand the mechanisms that govern metastasis.
The study findings “have the potential to open up new avenues for therapeutic intervention in this subset of GIST tumors.”
A conversation with Kathryn Schmitz, PhD, MPH
Although the improvement in survival with immunotherapy was modest, it is noteworthy because SCLC has been such a recalcitrant disease.
Imagine, taking a simple blood draw to find out if you have cancer, and if so, the cancer’s location and molecular type.
The three studies tested Zejula, Lynparza and veliparib in women with newly diagnosed advanced ovarian cancer.
In a clinical trial, the research team is hoping to learn more about how myeloma cells resist CAR T-cell therapy.
The study’s findings “add to accumulating evidence that HPV vaccination prevents oral infection with HPV.”
“The more information we have from well-designed studies, the better we are able to counsel our patients,” said Larissa Korde, MD.
Oncolytic viruses kill cancer cells, but studies also suggest that they can boost the immune system’s ability to recognize and kill a tumor.
In the study, the 5-year overall survival rate after a diagnosis of breast cancer was 77.6% for men, compared with 86.4% for women.
Scientists emphasize using data and analyses from completed and ongoing trials to gain a better understanding of patient outcomes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.